Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Inactivated COVID-19 Vaccine in Thai Adults
TCTR20210308003Phase 4Completed
- Sponsor
- National Research Council Canada
- Start
- Mar 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of turkovac in coronavirus disease 2019 (COVID-19), sponsored by National Research Council Canada. Primary endpoints: Safety and Immunogenicity. Started Mar 2021; status: completed.
02
Drugs
turkovac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20210308003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210308003.